Reduction in the prescription of Olanzapine as a first-line treatment for first episode psychosis following the implementation of clinical practice guidelines
Gespeichert in:
| Veröffentlicht in: | Schizophrenia research 2020-01, Vol.215, p.469-470 |
|---|---|
| Hauptverfasser: | , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 470 |
|---|---|
| container_issue | |
| container_start_page | 469 |
| container_title | Schizophrenia research |
| container_volume | 215 |
| creator | Nguyen, Tony Seiler, Natalie Maguire, James Sizer, Holly McGorry, Patrick Brown, Ellie O'Donoghue, Brian |
| description | |
| doi_str_mv | 10.1016/j.schres.2019.08.027 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2287513700</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0920996419303834</els_id><sourcerecordid>2287513700</sourcerecordid><originalsourceid>FETCH-LOGICAL-c417t-b732ae277b4acf09fc50945170cb0d985fc21a3df208434dc68ec5463d97fe303</originalsourceid><addsrcrecordid>eNqFUsuO1DAQtBCIHRb-AKEcuSS07SSOL0hoxUtaaSUeZ8tjt3c8JHGwE9DwMXwrzmaHAxdOlt3VVe6qJuQ5hYoCbV8dq2QOEVPFgMoKugqYeEB2tBG8ZA3Ih2QHkkEpZVtfkCcpHQGANiAekwtOa8ll2-3I709oFzP7MBZ-LOYDFlPmNNFPd2_BFTe9Hn_pyY9Y6FTowvmY5rJf73NEPQ84zoULcSsUOPkUbKZJJ3MIyadc6_vw04-3d_R-mHpce_RZwGQub3SflXX-icHidvEWV4X0lDxyuk_47P68JF_fvf1y9aG8vnn_8erNdWlqKuZyLzjTyITY19o4kM5kA-qGCjB7sLJrnGFUc-sYdDWvrWk7NE3dciuFQw78krzceKcYvi-YZjX4ZLDPs2NYkmKsEw3lAlZovUFNDClFdGqKftDxpCioNRl1VFsyak1GQadyMrntxb3Csh_Q_m06R5EBrzcA5jl_eIyZxeNo0PqIZlY2-P8p_EtwdvYbnjAdwxLH7KGiKjEF6vO6HetyUJkN6HjN_wDCzbqU</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2287513700</pqid></control><display><type>article</type><title>Reduction in the prescription of Olanzapine as a first-line treatment for first episode psychosis following the implementation of clinical practice guidelines</title><source>MEDLINE</source><source>Access via ScienceDirect (Elsevier)</source><creator>Nguyen, Tony ; Seiler, Natalie ; Maguire, James ; Sizer, Holly ; McGorry, Patrick ; Brown, Ellie ; O'Donoghue, Brian</creator><creatorcontrib>Nguyen, Tony ; Seiler, Natalie ; Maguire, James ; Sizer, Holly ; McGorry, Patrick ; Brown, Ellie ; O'Donoghue, Brian</creatorcontrib><identifier>ISSN: 0920-9964</identifier><identifier>EISSN: 1573-2509</identifier><identifier>DOI: 10.1016/j.schres.2019.08.027</identifier><identifier>PMID: 31493968</identifier><language>eng</language><publisher>Netherlands: Elsevier B.V</publisher><subject>Adolescent ; Adult ; Affective Disorders, Psychotic - drug therapy ; Antipsychotic Agents - therapeutic use ; Australia ; Clinical practice guideline ; Drug Prescriptions - statistics & numerical data ; Evidence-Based Medicine ; Female ; First episode psychosis ; Guideline Adherence ; Guideline evaluation ; Humans ; Male ; Olanzapine ; Olanzapine - therapeutic use ; Practice Guidelines as Topic ; Practice Patterns, Physicians' - statistics & numerical data ; Psychiatric/Mental Health ; Psychotic Disorders - drug therapy ; Retrospective Studies ; Schizophrenia - drug therapy ; Young Adult</subject><ispartof>Schizophrenia research, 2020-01, Vol.215, p.469-470</ispartof><rights>2019 Elsevier B.V.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c417t-b732ae277b4acf09fc50945170cb0d985fc21a3df208434dc68ec5463d97fe303</citedby><cites>FETCH-LOGICAL-c417t-b732ae277b4acf09fc50945170cb0d985fc21a3df208434dc68ec5463d97fe303</cites><orcidid>0000-0001-6240-6952</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.schres.2019.08.027$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3550,27924,27925,45995</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/31493968$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Nguyen, Tony</creatorcontrib><creatorcontrib>Seiler, Natalie</creatorcontrib><creatorcontrib>Maguire, James</creatorcontrib><creatorcontrib>Sizer, Holly</creatorcontrib><creatorcontrib>McGorry, Patrick</creatorcontrib><creatorcontrib>Brown, Ellie</creatorcontrib><creatorcontrib>O'Donoghue, Brian</creatorcontrib><title>Reduction in the prescription of Olanzapine as a first-line treatment for first episode psychosis following the implementation of clinical practice guidelines</title><title>Schizophrenia research</title><addtitle>Schizophr Res</addtitle><subject>Adolescent</subject><subject>Adult</subject><subject>Affective Disorders, Psychotic - drug therapy</subject><subject>Antipsychotic Agents - therapeutic use</subject><subject>Australia</subject><subject>Clinical practice guideline</subject><subject>Drug Prescriptions - statistics & numerical data</subject><subject>Evidence-Based Medicine</subject><subject>Female</subject><subject>First episode psychosis</subject><subject>Guideline Adherence</subject><subject>Guideline evaluation</subject><subject>Humans</subject><subject>Male</subject><subject>Olanzapine</subject><subject>Olanzapine - therapeutic use</subject><subject>Practice Guidelines as Topic</subject><subject>Practice Patterns, Physicians' - statistics & numerical data</subject><subject>Psychiatric/Mental Health</subject><subject>Psychotic Disorders - drug therapy</subject><subject>Retrospective Studies</subject><subject>Schizophrenia - drug therapy</subject><subject>Young Adult</subject><issn>0920-9964</issn><issn>1573-2509</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFUsuO1DAQtBCIHRb-AKEcuSS07SSOL0hoxUtaaSUeZ8tjt3c8JHGwE9DwMXwrzmaHAxdOlt3VVe6qJuQ5hYoCbV8dq2QOEVPFgMoKugqYeEB2tBG8ZA3Ih2QHkkEpZVtfkCcpHQGANiAekwtOa8ll2-3I709oFzP7MBZ-LOYDFlPmNNFPd2_BFTe9Hn_pyY9Y6FTowvmY5rJf73NEPQ84zoULcSsUOPkUbKZJJ3MIyadc6_vw04-3d_R-mHpce_RZwGQub3SflXX-icHidvEWV4X0lDxyuk_47P68JF_fvf1y9aG8vnn_8erNdWlqKuZyLzjTyITY19o4kM5kA-qGCjB7sLJrnGFUc-sYdDWvrWk7NE3dciuFQw78krzceKcYvi-YZjX4ZLDPs2NYkmKsEw3lAlZovUFNDClFdGqKftDxpCioNRl1VFsyak1GQadyMrntxb3Csh_Q_m06R5EBrzcA5jl_eIyZxeNo0PqIZlY2-P8p_EtwdvYbnjAdwxLH7KGiKjEF6vO6HetyUJkN6HjN_wDCzbqU</recordid><startdate>20200101</startdate><enddate>20200101</enddate><creator>Nguyen, Tony</creator><creator>Seiler, Natalie</creator><creator>Maguire, James</creator><creator>Sizer, Holly</creator><creator>McGorry, Patrick</creator><creator>Brown, Ellie</creator><creator>O'Donoghue, Brian</creator><general>Elsevier B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0001-6240-6952</orcidid></search><sort><creationdate>20200101</creationdate><title>Reduction in the prescription of Olanzapine as a first-line treatment for first episode psychosis following the implementation of clinical practice guidelines</title><author>Nguyen, Tony ; Seiler, Natalie ; Maguire, James ; Sizer, Holly ; McGorry, Patrick ; Brown, Ellie ; O'Donoghue, Brian</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c417t-b732ae277b4acf09fc50945170cb0d985fc21a3df208434dc68ec5463d97fe303</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Adolescent</topic><topic>Adult</topic><topic>Affective Disorders, Psychotic - drug therapy</topic><topic>Antipsychotic Agents - therapeutic use</topic><topic>Australia</topic><topic>Clinical practice guideline</topic><topic>Drug Prescriptions - statistics & numerical data</topic><topic>Evidence-Based Medicine</topic><topic>Female</topic><topic>First episode psychosis</topic><topic>Guideline Adherence</topic><topic>Guideline evaluation</topic><topic>Humans</topic><topic>Male</topic><topic>Olanzapine</topic><topic>Olanzapine - therapeutic use</topic><topic>Practice Guidelines as Topic</topic><topic>Practice Patterns, Physicians' - statistics & numerical data</topic><topic>Psychiatric/Mental Health</topic><topic>Psychotic Disorders - drug therapy</topic><topic>Retrospective Studies</topic><topic>Schizophrenia - drug therapy</topic><topic>Young Adult</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Nguyen, Tony</creatorcontrib><creatorcontrib>Seiler, Natalie</creatorcontrib><creatorcontrib>Maguire, James</creatorcontrib><creatorcontrib>Sizer, Holly</creatorcontrib><creatorcontrib>McGorry, Patrick</creatorcontrib><creatorcontrib>Brown, Ellie</creatorcontrib><creatorcontrib>O'Donoghue, Brian</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Schizophrenia research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Nguyen, Tony</au><au>Seiler, Natalie</au><au>Maguire, James</au><au>Sizer, Holly</au><au>McGorry, Patrick</au><au>Brown, Ellie</au><au>O'Donoghue, Brian</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Reduction in the prescription of Olanzapine as a first-line treatment for first episode psychosis following the implementation of clinical practice guidelines</atitle><jtitle>Schizophrenia research</jtitle><addtitle>Schizophr Res</addtitle><date>2020-01-01</date><risdate>2020</risdate><volume>215</volume><spage>469</spage><epage>470</epage><pages>469-470</pages><issn>0920-9964</issn><eissn>1573-2509</eissn><cop>Netherlands</cop><pub>Elsevier B.V</pub><pmid>31493968</pmid><doi>10.1016/j.schres.2019.08.027</doi><tpages>2</tpages><orcidid>https://orcid.org/0000-0001-6240-6952</orcidid></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0920-9964 |
| ispartof | Schizophrenia research, 2020-01, Vol.215, p.469-470 |
| issn | 0920-9964 1573-2509 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_2287513700 |
| source | MEDLINE; Access via ScienceDirect (Elsevier) |
| subjects | Adolescent Adult Affective Disorders, Psychotic - drug therapy Antipsychotic Agents - therapeutic use Australia Clinical practice guideline Drug Prescriptions - statistics & numerical data Evidence-Based Medicine Female First episode psychosis Guideline Adherence Guideline evaluation Humans Male Olanzapine Olanzapine - therapeutic use Practice Guidelines as Topic Practice Patterns, Physicians' - statistics & numerical data Psychiatric/Mental Health Psychotic Disorders - drug therapy Retrospective Studies Schizophrenia - drug therapy Young Adult |
| title | Reduction in the prescription of Olanzapine as a first-line treatment for first episode psychosis following the implementation of clinical practice guidelines |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-23T20%3A29%3A02IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Reduction%20in%20the%20prescription%20of%20Olanzapine%20as%20a%20first-line%20treatment%20for%20first%20episode%20psychosis%20following%20the%20implementation%20of%20clinical%20practice%20guidelines&rft.jtitle=Schizophrenia%20research&rft.au=Nguyen,%20Tony&rft.date=2020-01-01&rft.volume=215&rft.spage=469&rft.epage=470&rft.pages=469-470&rft.issn=0920-9964&rft.eissn=1573-2509&rft_id=info:doi/10.1016/j.schres.2019.08.027&rft_dat=%3Cproquest_cross%3E2287513700%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2287513700&rft_id=info:pmid/31493968&rft_els_id=S0920996419303834&rfr_iscdi=true |